For research use only. Not for therapeutic Use.
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
Rovazolac is an anti-inflammatory drug candidate[1].
| Catalog Number | I020266 |
| CAS Number | 1454288-88-0 |
| Synonyms | ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate |
| Molecular Formula | C21H19F3N2O4S |
| Purity | ≥95% |
| InChI | InChI=1S/C21H19F3N2O4S/c1-3-30-20(27)13-26-18(12-19(25-26)21(22,23)24)15-9-7-14(8-10-15)16-5-4-6-17(11-16)31(2,28)29/h4-12H,3,13H2,1-2H3 |
| InChIKey | ZUMNJDGBYXHASJ-UHFFFAOYSA-N |
| SMILES | CCOC(=O)CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)C |
| Reference | [1]. Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1 |
